European Market Report for Needleless Connectors 2017 - MedCore
General Report Contents
Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
Market Drivers & Limiters for each chapter segment
Competitive Analysis for each chapter segment
Section on recent mergers & acquisitions
The population of Europe has been growing at an average of 0.1% each year since 2003. That year, the average age of a person in the European Union was approximately 38; this is expected to increase due to decreases in mortality and fertility and higher life expectancies. By 2050, the average age in Europe is expected to be 52, thus driving the growth in healthcare industry and putting significant pressure on medical systems across Europe. In 2016, the United Kingdom accounted for approximately 25% of the total market value due to high unit sales and higher-than-average ASPs.
Unit growth in this market will be driven by increases in population, concerns about and new legislation for needlestick injuries and the rates of infection associated with established competing devices, such as three-way stopcocks. Germany and France had the highest number of needleless connectors sold, due to a larger population and earlier adoption of the device. Other countries that traditionally have a high usage of medical devices are expected to adopt needleless connectors at an increased rate over the forecast period.
The ASP of a needleless connector in Europe decreased from the previous year. Lower prices for needleless connectors may make it difficult for some companies to enter the market as it would be harder to make a profit without substantial unit sales. Companies have been trying to de-commoditize the market by creating new technologies as the anti-reflux and antimicrobial NLCs, but the buying decision has been mainly driven by price.
In 2016, the European market for needleless connectors increased over the previous year. Growth in this market is driven primarily by the European population and demographic shifts.